Company: ACHV
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0000950170-25-104571
Chunk: 9

Company: ACHIEVE LIFE SCIENCES, INC.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 1
Chunk 9
---
8]

     Stockholders' equity:

     Series A convertible preferred stock, $0.001 par value, 9,158 shares designated, zeroissued and outstanding at June 30, 2025 and zero issued and outstanding at December 31, 2024

     —

     —

     Series B convertible preferred stock, $0.001 par value, 6,256 shares designated, zeroissued and outstanding at June 30, 2025 and zero issued and outstanding at December 31, 2024

     —

     —

     Common stock, $0.001 par value, 150,000,000 shares authorized, 49,685,072 issued and outstanding at June 30, 2025 and 34,685,072 issued and outstanding at December 31, 2024

     118

     103

     Additional paid-in capital

     272,670

     226,343

     Accumulated deficit

     (231,123
     )

     (205,578
     )

     Accumulated other comprehensive income

     3

     31

     Total stockholders' equity

     41,668

     20,899

     Total liabilities and stockholders' equity
      
     $
     58,935

     $
     38,633

     Subsequent events [note 9]